Low‐dose immune tolerance induction in children with severe hemophilia A with high‐titer inhibitors: Type of factor 8 mutation and outcomes

MLA

Jie Sun, et al. “Low‐dose Immune Tolerance Induction in Children with Severe Hemophilia A with High‐titer Inhibitors: Type of Factor 8 Mutation and Outcomes.” Research and Practice in Thrombosis and Haemostasis, vol. 6, no. 7, Oct. 2022. EBSCOhost, https://doi.org/10.1002/rth2.12824.

APA

Jie Sun, Zekun Li, Gang Li, Kun Huang, Di Ai, Guoqing Liu, Wanru Yao, Xingjuan Xie, Hao Gu, Yingzi Zhen, Zhenping Chen, & Runhui Wu. (2022). Low‐dose immune tolerance induction in children with severe hemophilia A with high‐titer inhibitors: Type of factor 8 mutation and outcomes. Research and Practice in Thrombosis and Haemostasis, 6(7). https://doi.org/10.1002/rth2.12824

Chicago

Jie Sun, Zekun Li, Gang Li, Kun Huang, Di Ai, Guoqing Liu, Wanru Yao, et al. 2022. “Low‐dose Immune Tolerance Induction in Children with Severe Hemophilia A with High‐titer Inhibitors: Type of Factor 8 Mutation and Outcomes.” Research and Practice in Thrombosis and Haemostasis 6 (7). doi:10.1002/rth2.12824.